C7745

CDK7/Cyclin H1/MNAT1, active, His tagged human

PRECISIO^® Kinase, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE), buffered aqueous glycerol solution

• 别名: CAK, CCNH, CDKN7, MAT1, P39mo15, RNF66, STK1, p34, p37
• 分類程式碼代碼: 12352200
• NACRES: NA.32

属性

• 重組細胞: expressed in baculovirus infected Sf9 cells
• 品質等級: 200
• 產品線: PRECISIO^® Kinase
• 化驗: ≥70% (SDS-PAGE)
• 形狀: buffered aqueous glycerol solution
• 比活性: 17-22 nmol/min·mg
• 分子量: CDK7 subunit ~40 kDa; MNAT1 subunit ~37 kDa; cyclin D1 ~39 kDa
• UniProt登錄號: P50613; P51946; P51948
• 運輸包裝: dry ice
• 儲存溫度: −70°C
• 基因資訊: human ... CCNH(902) , CDK7(1022) , MNAT1(4331)

说明

生化／生理作用

CDK7 gene is a member of the cyclin-dependent protein kinase family that is important regulators of cell cycle progression. CDK7 forms a trimeric complex with cyclin H and MAT1, which functions as a CDK-activating kinase (CAK). CDK7 is an essential component of the transcription factor TFIIH that is involved in transcription initiation and DNA repair. CDK7 is thought to serve as a direct link between the regulation of transcription and the cell cycle.

外觀

Supplied in 50mM NaPhosphate pH 7.0, 300 mM NaCl, 150 mM imidazole, 0.1mM PMSF, 0.2 mM DTT, 25% glycerol.

法律資訊

PRECISIO is a registered trademark of Merck KGaA, Darmstadt, Germany

安全信息

• 象形圖: GHS08,GHS07
• 訊號詞: Danger
• 危險聲明: H315,H319,H360D
• 防範說明: P202 - P264 - P280 - P302 + P352 - P305 + P351 + P338 - P308 + P313
• 危險分類: Eye Irrit. 2 - Repr. 1B - Skin Irrit. 2
• 儲存類別代碼: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• 水污染物質分類（WGK）: WGK 1
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable
• 個人防護裝備: Eyeshields, Faceshields, Gloves, multi-purpose combination respirator cartridge (US)